Zhejiang Taimei Medical Technology Co (HKSE:02576) ROCE % : 0.00% (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Zhejiang Taimei Medical Technology Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhejiang Taimei Medical Technology Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 0.00%.

Zhejiang Taimei Medical Technology Co ROCE % Historical Data

The historical data trend for Zhejiang Taimei Medical Technology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Taimei Medical Technology Co ROCE % Chart

Zhejiang Taimei Medical Technology Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

ROCE %

-32.77

-27.72

-27.83

-18.03

Zhejiang Taimei Medical Technology Co Semi-Annual Data
	Dec21	Dec22	Dec23	Dec24
ROCE %	-	-	-	-16.79

Zhejiang Taimei Medical Technology Co ROCE % Calculation

Zhejiang Taimei Medical Technology Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-388.218	/	( ( (2038.34 - 437.118)	+	(1580.152 - 391.43) )	/ 2 )
	=	-388.218	/	( (1601.222	+	1188.722)	/ 2 )
	=	-388.218	/	1394.972
	=	-27.83 %

Zhejiang Taimei Medical Technology Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	0	/	( ( (2038.34 - 437.118)	+	(1580.152 - 391.43) )	/ 2 )
	=	0	/	( ( 1601.222	+	1188.722 )	/ 2 )
	=	0	/	1394.972
	=	0.00 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2023) EBIT data.

Zhejiang Taimei Medical Technology Co (HKSE:02576) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhejiang Taimei Medical Technology Co ROCE % Related Terms

Thank you for viewing the detailed overview of Zhejiang Taimei Medical Technology Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Taimei Medical Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Zhejiang Taimei Medical Technology Co Ltd (HKSE:02576) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

36 Changsheng South Road, 3rd Floor, Building 9, Smart Industry Innovation Park, Zhejiang, Jiaxing, CHN

Website

https://www.taimei.com

Zhejiang Taimei Medical Technology Co Ltd is a digital solution provider focused on the pharmaceutical and medical device industry in China, It designs and delivers industry-specific software and digital services that facilitate the research and development (R&D) as well as the commercialization of pharmaceuticals and medical devices. The software It offers is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. These cloud-based software covers critical use cases in R&D and commercialization of innovative drugs and medical devices.

Executives

Zuo Lingye	2201 Interest of corporation controlled by you
Shang Hai Jing Wei Gu Quan Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Hang Zhou Jing Wei Yuan Chuang Tou Zi Guan Li He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Jing Wei Chuang Teng Hang Zhou Chuang Ye Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Shen Zhen Shi Teng Xun Rui Tou Qi Ye Guan Li You Xian Gong Si
Teng Xun Ke Ji Shen Zhen You Xian Gong Si
Chen Yihai	2202 Interest of your spouse
Shang Hai Chen Xi Chuang Ye Tou Zi Zhong Xin You Xian He Huo	2101 Beneficial owner
Shang Hai Yuan Pan Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Xue Qiong	2201 Interest of corporation controlled by you
Ma Huateng
Lin Zhi Teng Xun Tou Zi Guan Li You Xian Gong Si
Shen Zhen Shi Teng Xun Chan Ye Tou Zi Ji Jin You Xian Gong Si
Oriental Power Holdings Limited
Shen Zhen Shi Teng Xun Rui Jian Tou Zi You Xian Gong Si

Zhejiang Taimei Medical Technology Co Headlines

No Headlines